BIOMAT Database Logo BIOMAT Database Logo

The mechanism of inhibition of DNA transcription in vitro by nitracrine (Ledakrin, C-283). 1979

K Slaska, and L Szmigiero, and B Jaros-Kamińska, and E Ciesielska, and M Gniazdowski

UI MeSH Term Description Entries
D009564 Nitracrine Acridine antineoplastic agent used in mammary and ovarian tumors. It inhibits RNA synthesis. C-283,Ledakrin,C 283,C283
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D000166 Acridines Compounds that include the structure of acridine. Acridine
D001482 Base Composition The relative amounts of the PURINES and PYRIMIDINES in a nucleic acid. Base Ratio,G+C Composition,Guanine + Cytosine Composition,G+C Content,GC Composition,GC Content,Guanine + Cytosine Content,Base Compositions,Base Ratios,Composition, Base,Composition, G+C,Composition, GC,Compositions, Base,Compositions, G+C,Compositions, GC,Content, G+C,Content, GC,Contents, G+C,Contents, GC,G+C Compositions,G+C Contents,GC Compositions,GC Contents,Ratio, Base,Ratios, Base
D012321 DNA-Directed RNA Polymerases Enzymes that catalyze DNA template-directed extension of the 3'-end of an RNA strand one nucleotide at a time. They can initiate a chain de novo. In eukaryotes, three forms of the enzyme have been distinguished on the basis of sensitivity to alpha-amanitin, and the type of RNA synthesized. (From Enzyme Nomenclature, 1992). DNA-Dependent RNA Polymerases,RNA Polymerases,Transcriptases,DNA-Directed RNA Polymerase,RNA Polymerase,Transcriptase,DNA Dependent RNA Polymerases,DNA Directed RNA Polymerase,DNA Directed RNA Polymerases,Polymerase, DNA-Directed RNA,Polymerase, RNA,Polymerases, DNA-Dependent RNA,Polymerases, DNA-Directed RNA,Polymerases, RNA,RNA Polymerase, DNA-Directed,RNA Polymerases, DNA-Dependent,RNA Polymerases, DNA-Directed
D013698 Templates, Genetic Macromolecular molds for the synthesis of complementary macromolecules, as in DNA REPLICATION; GENETIC TRANSCRIPTION of DNA to RNA, and GENETIC TRANSLATION of RNA into POLYPEPTIDES. Genetic Template,Genetic Templates,Template, Genetic
D014158 Transcription, Genetic The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION. Genetic Transcription
D055598 Chemical Phenomena The composition, structure, conformation, and properties of atoms and molecules, and their reaction and interaction processes. Chemical Concepts,Chemical Processes,Physical Chemistry Concepts,Physical Chemistry Processes,Physicochemical Concepts,Physicochemical Phenomena,Physicochemical Processes,Chemical Phenomenon,Chemical Process,Physical Chemistry Phenomena,Physical Chemistry Process,Physicochemical Phenomenon,Physicochemical Process,Chemical Concept,Chemistry Process, Physical,Chemistry Processes, Physical,Concept, Chemical,Concept, Physical Chemistry,Concept, Physicochemical,Concepts, Chemical,Concepts, Physical Chemistry,Concepts, Physicochemical,Phenomena, Chemical,Phenomena, Physical Chemistry,Phenomena, Physicochemical,Phenomenon, Chemical,Phenomenon, Physicochemical,Physical Chemistry Concept,Physicochemical Concept,Process, Chemical,Process, Physical Chemistry,Process, Physicochemical,Processes, Chemical,Processes, Physical Chemistry,Processes, Physicochemical

Related Publications

K Slaska, and L Szmigiero, and B Jaros-Kamińska, and E Ciesielska, and M Gniazdowski
Some properties of the irreversible complexes of nitracrine (ledakrin, C-283) with polynucleotides.
March 1981, Chemico-biological interactions,
K Slaska, and L Szmigiero, and B Jaros-Kamińska, and E Ciesielska, and M Gniazdowski
1H and 13C NMR characteristics of the anticancerous derivative of acridine: Ledakrin C-283 (nitracrine).
January 1983, Acta biochimica Polonica,
K Slaska, and L Szmigiero, and B Jaros-Kamińska, and E Ciesielska, and M Gniazdowski
Mechanism of inhibition of DNA-dependent RNA synthesis in vitro by Ledakrin.
January 1978, Materia medica Polona. Polish journal of medicine and pharmacy,
K Slaska, and L Szmigiero, and B Jaros-Kamińska, and E Ciesielska, and M Gniazdowski
Effect of intercalating and groove-binding ligands on formation of covalent complexes between nitracrine (Ledakrin, C-283) or 8-methoxypsoralen and DNA.
July 1984, Biochimica et biophysica acta,
K Slaska, and L Szmigiero, and B Jaros-Kamińska, and E Ciesielska, and M Gniazdowski
Products of metabolic activation of the antitumor drug ledakrin (nitracrine) in vitro.
January 2001, Chemical research in toxicology,
K Slaska, and L Szmigiero, and B Jaros-Kamińska, and E Ciesielska, and M Gniazdowski
Antineoplastic activity of C-283 preparation (Ledakrin) in model experiments.
January 1976, Materia medica Polona. Polish journal of medicine and pharmacy,
K Slaska, and L Szmigiero, and B Jaros-Kamińska, and E Ciesielska, and M Gniazdowski
Excretion and organ distribution of the cytostatic preparation Ledakrin (preparation C-283) in rat.
January 1976, Acta medica Polona,
K Slaska, and L Szmigiero, and B Jaros-Kamińska, and E Ciesielska, and M Gniazdowski
[Effect of 1-nitro-9-aminoalkylacridine (Ledakrin, C-283) binding with chromatin on DNA template activity (preliminary report)].
January 1977, Medycyna doswiadczalna i mikrobiologia,
K Slaska, and L Szmigiero, and B Jaros-Kamińska, and E Ciesielska, and M Gniazdowski
32P-post-labeling analysis of DNA adduct formation by antitumor drug nitracrine (Ledakrin) and other nitroacridines in different biological systems.
April 1989, Biochemical pharmacology,
K Slaska, and L Szmigiero, and B Jaros-Kamińska, and E Ciesielska, and M Gniazdowski
In vitro binding of nitracrine to DNA in chromatin.
January 1989, Zeitschrift fur Naturforschung. C, Journal of biosciences,
Copied contents to your clipboard!